Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 3.3 Exhibit 3.3
- 3.4 Exhibit 3.4
- 3.5 Exhibit 3.5
- 99.1 Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits
CYNA similar filings
- 24 Oct 16 Amendments to Articles of Incorporation or Bylaws
- 21 Oct 16 Termination of a Material Definitive Agreement
- 18 Oct 16 Cynapsus Therapeutics Obtains Final Court Order and HSR Waiting Period Expires for Plan of Arrangement with Sunovion Pharmaceuticals
- 13 Oct 16 Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement with Sunovion Pharmaceuticals
- 11 Oct 16 Unregistered Sales of Equity Securities
Filing view
External links
Exhibit 3.2
Number: C1093896 |
CERTIFICATE
OF
CONTINUATION
BUSINESS CORPORATIONS ACT
I Hereby Certify that Cynapsus Therapeutics Inc., has continued into British Columbia from the Jurisdiction of CANADA, under the Business Corporations Act, with the name CYNAPSUS THERAPEUTICS INC. on October 21, 2016 at 10:19 AM Pacific Time.
Issued under my hand at Victoria, British Columbia On October 21, 2016
CAROL PREST
Registrar of CompaniesProvince of British Columbia Canada |